🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objective of this study is to observe and evaluate the safety and ...
Status
Recruiting
Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2025-05-30
Trial ID
NCT06980155
Treatments Being Tested
RATIONALE: Vaccines made from white blood cells treated with antigens may m...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
1997-04
Trial ID
NCT00019214
Treatments Being Tested
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Completed
Location
USC/Norris Comprehensive Cancer Center and Hospital
Start Date
2000-07
Trial ID
NCT00023647
Treatments Being Tested
Background: * PSA (prostate specific antigen) is a protein found on normal...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2009-05-11
Trial ID
NCT00972309
The primary aim of this innovative immunotherapeutic study is to determine ...
Status
Active Not Recruiting
Location
ZNA Cadix
Start Date
2012-10
Trial ID
NCT01686334
Treatments Being Tested
RATIONALE: Vaccines may help the body build an effective immune response to...
Status
Completed
Location
University of Pittsburgh Cancer Institute
Start Date
1998-05
Trial ID
NCT00008099
Treatments Being Tested
This study is being done because the investigators would like to learn more...
Status
Completed
Location
Le Bonheur
Start Date
2022-06-29
Trial ID
NCT05164016
The purpose of this study is to evaluate the safety, and tolerability of HL...
Status
Unknown
Location
Fukushima Medical University Hospital
Start Date
2007-03
Trial ID
NCT00639925
Treatments Being Tested
The GI-4000 therapeutic vaccine or placebo will be injected under the skin ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2006-01
Trial ID
NCT00300950
Treatments Being Tested
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024